India
IND
Sun Pharmaceutical ransomware disrupts operations; company warns of revenue impact
On 2 March 2023, SUN PHARMACEUTICAL INDUSTRIES confirmed a ransomware incident involving theft of company and personal data. The firm isolated its network and reported that business operations were impacted, warning of revenue loss and potential litigation in regulatory filings.
66
Estimated severity
66 / 100
93
Source reliability
93 / 100
Approximate Date
02/03/2023
Targeted Company
SUN PHARMACEUTICAL INDUSTRIES
Targeted Company Supply Chain Impact
Distribution & Fulfillment
Procurement & Sourcing
Production & Manufacturing
Sales (Retail & Ecommerce)
Warehousing
Service Delivery
Unrecognized Impact
Supply Chain Relations
No information
Geographic Impact
Country Targeted Company
Other Affected Countries
No other affected countries reported
Target country
India
Affected countries
India
Impacted regions
Asia · India
Operational Impact
Duration
No information
Financial impact (USD M)
No information
Impact types
Operational disruptionService degradation
Affected sectors
Pharmaceuticals & Life Sciences
Affected departments
Information Technology
Attack Profile
Attack types
RansomwareData exfiltration
Attributed threat actors
ALPHV